Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 11342

Researchers at Bar Ilan University and the Interdisciplinary Center in Herzliya, both in Israel, have developed new technology that allows tiny bots to release drugs into the body controlled by human thought alone. The test involved a man using his thoughts to activate nano robots inside a cockroach.

The bots have been built using a DNA origami structure with hollow shell-like components, and they come with a “gate” that can be opened and shut with the help of iron oxide nanoparticles that act as a “lock” – which can be prized open using electromagnetic energy.

The Israeli team believe the bots could help in controlled release of drugs over time. Led by Dr Ido Bachelet of Bar Ilan University, scientists demonstrated how to control this process with human brainwaves. Using a computer algorithm, they trained the system to detect when a person’s brain was under strain from doing mental arithmetic. The team then placed a fluorescent drug in the bots and injected them into various cockroaches that were placed inside an electromagnetic coil.

Read more

This story originally appeared on realsimple.com.

Imagine waking up every morning with a cup of freshly brewed coffee on your nightstand. Well this new gadget will make your days much easier—especially if you’re not a morning person. The Barisieur, an alarm clock and coffee maker hybrid, is available for preorder through Indiegogo. Created and founded by London-based designer Josh Renouf, the clock was first conceptualized in 2014 and after research and prototyping, Renouf launched a Kickstarter this past May. Now that the team has met their initial fundraising goal, they moved it over to Indiegogo for more funding.

Related: Frosé (Frozen Rosé) Is the Hottest Drink of Summer.

Read more

Many lower organisms retain the miraculous ability to regenerate form and function of almost any tissue after injury. Humans share many of our genes with these organisms, but our capacity for regeneration is limited. Scientists at the MDI Biological Laboratory in Bar Harbor, Maine, are studying the genetics of these organisms to find out how regenerative mechanisms might be activated in humans.

The ability of animals to regenerate body parts has fascinated scientists since the time of Aristotle. But until the advent of sophisticated tools for genetic and computational analysis, scientists had no way of studying the genetic machinery that enables regeneration. Using such tools, scientists at the MDI Biological Laboratory have identified genetic regulators governing regeneration that are common across species.

In a paper published in the journal PLOS ONE, MDI Biological Laboratory scientistsBenjamin L. King, Ph.D., and Voot P. Yin, Ph.D., identified these common genetic regulators in three regenerative species: the zebrafish, a common aquarium fish originally from India; the axolotl, a salamander native to the lakes of Mexico; and the bichir, a ray-finned fish from Africa.

Read more

In a test lab, Bert2 — a humanoid robot with three separate displays, allowing its eyes and mouth to express various emotions — performed in three different ways. One was silent and made zero mistakes, while a second was mute and programmed to make a single blunder (which it would then correct, quietly). A third was able to speak and accept simple “yes” or “no” responses from the user. In a basic kitchen scenario, the vocal android would apologise for its mistakes — after dropping an egg, for instance — and give a heads-up when it was about to try a new technique.

While the slowest, it was the robot that most people preferred.

But here’s where it gets interesting. At the end of the exchange, the robot would ask for a job. Some participants were reluctant to say no — even if they preferred the silent, more efficient robot — because they thought it would upset the machine. “It felt appropriate to say no, but I felt really bad saying it,” one of the test participants said. “When the face was really sad, I felt even worse. I felt bad because the robot was trying to do its job.”

Read more

The desktop variant of innovative torrent client WebTorrent has now clocked up an impressive 250,000 downloads, its founder reports. In a market where competing clients are often closed source or commercial ventures, WebTorrent promises to be transparent and non-commercial, forever. And that’s despite Netflix knocking at the door.

Stanford University graduate Feross Aboukhadijeh is passionate about P2P technology. The founder of P2P-assisted content delivery network PeerCDN (sold to Yahoo in 2013), Feross is also the inventor of WebTorrent.

In its classic form, WebTorrent is a BitTorrent client for the web. No external clients are needed for people to share files since everything is done in the user’s web browser with Javascript. No browser plugins or extensions need to be installed, nothing needs to be configured.

Read more

The big kahuna of American rocket companies is the United Launch Alliance, a joint venture of Boeing and Lockheed Martin that until this year held a monopoly on the lucrative business of launching rockets for the US Air Force.

But that monopoly is no more. The company faces a new era of competition as Elon Musk’s maturing SpaceX aims to fly more space missions in one year than ULA does, and as Jeff Bezos’ Blue Origin breaks ground on a new factory for orbital rockets.

ULA, for its part, isn’t sitting still. “I came here to transform the company, position it in this new competitive marketplace with all these different players,” says Tony Bruno, who took the CEO job at ULA in August 2014 after a three-decade career in Lockheed’s missile-defense business. In his first full year in charge, ULA returned more than $400 million in operating profits to its two owners, but the company must prepare for when its final no-bid launch contract expires in 2019.

Read more

Even insurance companies are taking longevity seriously now!

Source: http://www.riskmindslive.com/will-rea…

Is ageing a disease? Can it be cured? Can death be pushed back? Will you live to 1000 years? Aubrey de Grey, Chief Science Officer, SENS Research Foundation divulges the truth behind longevity and the ensuing risks and discover how you should transform your life insurance models. He spoke to Markus Salchegger, Managing Director at Accenture Risk & Finance at RiskMinds Insurance 2016, Amsterdam.

Continue reading “Aubrey de Grey — Pushing back Death” | >